Evome Medical Technologies Inc.
LNDZF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $8 | $7 | $10 |
| Inventory | $9 | $10 | $11 | $10 |
| Other Curr. Assets | $0 | $0 | $5 | $0 |
| Total Curr. Assets | $17 | $20 | $23 | $21 |
| Property Plant & Equip (Net) | $9 | $10 | $10 | $13 |
| Goodwill | $5 | $5 | $5 | $6 |
| Intangibles | $3 | $3 | $3 | $7 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $18 | $19 | $19 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35 | $38 | $42 | $48 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $5 | $7 |
| Short-Term Debt | $12 | $13 | $16 | $17 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $13 | $13 | $11 |
| Total Curr. Liab. | $34 | $36 | $38 | $38 |
| LT Debt | $0 | $1 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $5 | $5 | $5 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $6 | $8 |
| Total Liabilities | $39 | $41 | $42 | $44 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $54 | $54 | $53 | $54 |
| Retained Earnings | -$73 | -$71 | -$69 | -$65 |
| AOCI | $3 | $3 | $3 | $2 |
| Other Equity | $3 | $3 | $3 | $3 |
| Total Equity | -$3 | -$2 | -$0 | $4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35 | $38 | $42 | $48 |
| Net Debt | $11 | $13 | $16 | $16 |